{
    "id": 32347,
    "fullName": "EGFR A763_Y764insLQEA",
    "impact": "insertion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR A763_Y764insLQEA results in the insertion of four amino acids in the C-helix region of the Egfr protein between amino acids 763 and 764 (PMID: 24353160). A763_Y764insLQEA has not been biochemically characterized, but is predicted to lead to Egfr activation based on the effect of other Egfr exon 20 insertions (PMID: 24353160, PMID: 16187797).",
            "references": [
                {
                    "id": 440,
                    "pubMedId": 24353160,
                    "title": "Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24353160"
                },
                {
                    "id": 410,
                    "pubMedId": 16187797,
                    "title": "Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16187797"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "A763_Y764insLQEA",
    "createDate": "01/29/2020",
    "updateDate": "01/29/2020",
    "referenceTranscriptCoordinates": {
        "id": 187171,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55181298_55181299insCTTCAAGAGGCA",
        "cDna": "c.2289_2290insCTTCAAGAGGCA",
        "protein": "p.A763_Y764insLQEA",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20096,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Tarceva (erlotinib) treatment in combination with chemotherapy resulted in progressive disease with a progression-free survival of 2 months in a patient with non-small cell lung cancer harboring EGFR A763_Y764insLQEA (PMID: 31715539).",
            "molecularProfile": {
                "id": 34864,
                "profileName": "EGFR A763_Y764insLQEA"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17697,
                    "pubMedId": 31715539,
                    "title": "Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31715539"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34864,
            "profileName": "EGFR A763_Y764insLQEA",
            "profileTreatmentApproaches": [
                {
                    "id": 20208,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "EGFR A763_Y764insLQEA"
                },
                {
                    "id": 20206,
                    "name": "EGFR Inhibitor (Pan)",
                    "profileName": "EGFR A763_Y764insLQEA"
                },
                {
                    "id": 20209,
                    "name": "EGFR Inhibitor 1st gen",
                    "profileName": "EGFR A763_Y764insLQEA"
                },
                {
                    "id": 20205,
                    "name": "EGFR Inhibitor 2nd gen",
                    "profileName": "EGFR A763_Y764insLQEA"
                },
                {
                    "id": 20207,
                    "name": "EGFR Inhibitor 3rd gen",
                    "profileName": "EGFR A763_Y764insLQEA"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 187171,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55181298_55181299insCTTCAAGAGGCA",
            "cDna": "c.2289_2290insCTTCAAGAGGCA",
            "protein": "p.A763_Y764insLQEA",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}